A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients

Roxadustat (Rox), a hypoxia-inducible factor (HIF) stabilizer, is now available for the treatment of anemia in hemodialysis (HD) patients. To investigate hematopoietic effect and iron metabolism, this study involved 30 HD patients who were initially treated with darbepoetin (DA), a conventional eryt...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Chie, Tsuchiya, Ken, Tomosugi, Naohisa, Maeda, Kunimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583824/
https://www.ncbi.nlm.nih.gov/pubmed/32998272
http://dx.doi.org/10.3390/ijms21197153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583824/
https://www.ncbi.nlm.nih.gov/pubmed/32998272
http://dx.doi.org/10.3390/ijms21197153

Ejemplares similares